These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Insulation defects in Riata implantable cardioverter-defibrillator leads. Sato A; Chinushi M; Iijima K; Izumi D; Furushima H Intern Med; 2012; 51(19):2689-94. PubMed ID: 23037457 [TBL] [Abstract][Full Text] [Related]
64. Systematic fluoroscopic and electrical assessment of implantable cardioverter-defibrillator patients implanted with silicone-polyurethane copolymer (Optim™) coated leads. Forleo GB; Di Biase L; Panattoni G; Politano A; Magliano G; Santini L; Natale A; Romeo F Europace; 2014 Feb; 16(2):265-70. PubMed ID: 24042736 [TBL] [Abstract][Full Text] [Related]
65. Small-Caliber Lead Failure After Generator Exchange. Salgado R; Martín J; Martínez J; Alzueta J; Viñolas X; Fernández J; Molina M; Pérez L; Calvo D; García J J Cardiovasc Electrophysiol; 2016 Jul; 27(7):846-50. PubMed ID: 27090984 [TBL] [Abstract][Full Text] [Related]
66. Clinical experience and procedural outcomes associated with the DF4 implantable cardioverter defibrillator system: the SJ4 postapproval study. Cantillon DJ; Ha K; Styperek R; Jumrussirikul P; Mirro M; Wong W; Wilkoff BL Pacing Clin Electrophysiol; 2013 Jul; 36(7):855-62. PubMed ID: 23617316 [TBL] [Abstract][Full Text] [Related]
67. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up. Höke U; Auger D; Thijssen J; Wolterbeek R; van der Velde ET; Holman ER; Schalij MJ; Bax JJ; Delgado V; Marsan NA Heart; 2014 Jun; 100(12):960-8. PubMed ID: 24449717 [TBL] [Abstract][Full Text] [Related]
68. Single-coil and dual-coil defibrillator leads and association with clinical outcomes in a complete Danish nationwide ICD cohort. Larsen JM; Hjortshøj SP; Nielsen JC; Johansen JB; Petersen HH; Haarbo J; Johansen MB; Thøgersen AM Heart Rhythm; 2016 Mar; 13(3):706-12. PubMed ID: 26593333 [TBL] [Abstract][Full Text] [Related]
69. Apical versus Non-Apical Lead: Is ICD Lead Position Important for Successful Defibrillation? Amit G; Wang J; Connolly SJ; Glikson M; Hohnloser S; Wright DJ; Brachmann J; Defaye P; Neuzner J; Mabo P; Vanerven L; Vinolas X; O'Hara G; Kautzner J; Appl U; Gadler F; Stein K; Konstantino Y; Healey JS J Cardiovasc Electrophysiol; 2016 May; 27(5):581-6. PubMed ID: 26888558 [TBL] [Abstract][Full Text] [Related]
70. Trends in Fidelis lead survival: transition from an exponential to linear pattern of lead failure over time. Cheung JW; Tobin-Hess A; Patel A; Slotwiner DJ; Goldner BG Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):906-12. PubMed ID: 22923271 [TBL] [Abstract][Full Text] [Related]
71. Performance of the St. Jude Medical Riata leads. Epstein AE; Baker JH; Beau SL; Deering TF; Greenberg SM; Goldman DS Heart Rhythm; 2009 Feb; 6(2):204-9. PubMed ID: 19103512 [TBL] [Abstract][Full Text] [Related]
72. Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead. Kallinen LM; Hauser RG; Lee KW; Almquist AK; Katsiyiannis WT; Tang CY; Melby DP; Gornick CC Heart Rhythm; 2008 Jun; 5(6):775-9. PubMed ID: 18534361 [TBL] [Abstract][Full Text] [Related]
73. Paradoxical thromboembolic stroke during extraction of a recalled St Jude Medical Riata defibrillator lead with conductor externalization. Larsen JM; Theuns DA; Thøgersen AM Europace; 2014 Feb; 16(2):240. PubMed ID: 23933851 [TBL] [Abstract][Full Text] [Related]
74. Management and long-term outcomes associated with recalled implantable cardioverter-defibrillator leads: A multicenter experience. Mar PL; John A; Kumar S; Barry N; Chen G; Longserre S; Kabra R; Atkins D; Koerber S; Hussein A; Bhakta D; Lakkireddy D; Gopinathannair R Heart Rhythm; 2020 Nov; 17(11):1909-1916. PubMed ID: 32512178 [TBL] [Abstract][Full Text] [Related]
75. Impact of generator replacement on the risk of Fidelis lead fracture. Krahn AD; Bashir J; Birnie DH; Brown J; Spencer JH; Leander C; Estes NA Heart Rhythm; 2016 Aug; 13(8):1618-23. PubMed ID: 27154229 [TBL] [Abstract][Full Text] [Related]
76. Time-dependent risk of Fidelis lead failure. Faulknier BA; Traub DM; Aktas MK; Aguila A; Rosero S; Daubert JP; Hall B; Shah A; Taylor S; McNitt S; Moss AJ; Zareba W; Huang DT Am J Cardiol; 2010 Jan; 105(1):95-9. PubMed ID: 20102898 [TBL] [Abstract][Full Text] [Related]
77. Clinical outcomes in patients with implantable cardioverter defibrillators and Sprint Fidelis leads. Verlato R; Facchin D; Catanzariti D; Molon G; Zanotto G; Morani G; Brieda M; Zanon F; Delise P; Leoni L; Comisso J; Campo C Heart; 2013 Jun; 99(11):799-804. PubMed ID: 23434626 [TBL] [Abstract][Full Text] [Related]
78. A cost-effectiveness analysis of a proactive management strategy for the Sprint Fidelis recall: a probabilistic decision analysis model. Bashir J; Cowan S; Raymakers A; Yamashita M; Danter M; Krahn A; Lynd LD Heart Rhythm; 2013 Dec; 10(12):1761-7. PubMed ID: 24076445 [TBL] [Abstract][Full Text] [Related]
79. Long-Term Performance of the Riata/ST Implantable Cardioverter-Defibrillator Lead. Ströker E; de Asmundis C; Vanduynhoven P; De Vadder K; De Vusser P; Mullens W; Chierchia GB; Brugada P; Czapla J; La Meir M; Wellens F; Van Herendael H; Rivero-Ayerza M Am J Cardiol; 2016 Mar; 117(5):807-12. PubMed ID: 26762730 [TBL] [Abstract][Full Text] [Related]